Skip to main content

Study

French Pine Bark Extract May Reduce Gum Inflammation in Older Adults

Taking a supplement made from French maritime pine bark significantly reduced inflammation markers in the gums of older adults.

InflammationHealthy AgingHerbal RemediesOral Health
Study Credibility: High8.1/10From a trusted journalProperly designed studyResults verified
PublishedJan 2025DesignClinical TrialLast reviewedJun 2026
Email this

Summary

In plain language

A recent study found that a dietary supplement called Pycnogenol®, made from French maritime pine bark, may help reduce gum inflammation in older adults. Researchers studied 91 participants who received either the supplement or a placebo. After three months, those taking Pycnogenol® showed significant reductions in specific inflammation markers in their saliva and blood. These findings suggest that adding this supplement to regular dental care might offer extra benefits for maintaining gum health, which is important for overall well-being. Seniors might find this helpful in managing gum issues, but it's always best to discuss any new supplement with a healthcare provider.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was a carefully controlled trial involving 91 participants who were randomly assigned to take either Pycnogenol® or a placebo for three months. The researchers measured inflammation markers in saliva and blood at the start, and again after two and three months of supplementation.

  • Participants taking Pycnogenol® showed significant reductions in key inflammation markers like MMP-8 and IL-6.

  • The study suggests Pycnogenol® might have anti-inflammatory effects that could help reduce gum disease.

  • While promising, the study is limited to short-term effects and a specific population, so more research is needed for broader recommendations.

As always, it's important for seniors to discuss new supplements with their healthcare providers to ensure they are safe and appropriate.

Research Quality Score

Scored June 16, 2026 using rubric v9_2026-04-08.

Assessment

The study is a high-quality randomized controlled trial with strong design and bias control. Statistical methods are robust, and transparency is well-maintained. However, the funding source presents a potential conflict of interest, and there is no replication of results yet. The study is highly relevant to seniors.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study's focus on older adults and its rigorous methodology make it a valuable contribution to understanding the effects of Pycnogenol on gum inflammation in this population.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.